GLOBAL BIODEFENSE- Inovio Pharmaceuticals Inc. last week announced plans to advance their DNA vaccine for the Ebola virus into human clinical trials in early 2015. Results from the company’s preclinical testing of the vaccine showed 100% of vaccinated guinea pigs and mice were protected from death after being exposed to the Ebola virus. Continue Reading